PL369796A1 - Koniugaty angiotensyna-nośnik i ich zastosowania - Google Patents

Koniugaty angiotensyna-nośnik i ich zastosowania

Info

Publication number: PL369796A1
Authority: PL; Poland
Prior art keywords: conjugates; angiotensin; carrier conjugates; angiotensin peptide; peptide
Prior art date: 2001-10-05

Application number

PL02369796A

Other languages

English (en)

Inventor

Martin Bachmann

Original Assignee

Cytos Biotechnology Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-05

Filing date

2002-10-07

Publication date

2005-05-02

2002-01-18 Priority claimed from US10/050,902 external-priority patent/US7264810B2/en

2002-10-07 Application filed by Cytos Biotechnology Ag filed Critical Cytos Biotechnology Ag

2005-05-02 Publication of PL369796A1 publication Critical patent/PL369796A1/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0013—Therapeutic immunisation against small organic molecules, e.g. cocaine, nicotine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1021—Tetrapeptides with the first amino acid being acidic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Vascular Medicine (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Urology & Nephrology (AREA)
Microbiology (AREA)
Mycology (AREA)
Hospice & Palliative Care (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

PL02369796A 2001-10-05 2002-10-07 Koniugaty angiotensyna-nośnik i ich zastosowania PL369796A1 (pl)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US32699801P	2001-10-05	2001-10-05
US33104501P	2001-11-07	2001-11-07
US10/050,902 US7264810B2 (en)	2001-01-19	2002-01-18	Molecular antigen array
PCT/IB2002/000166 WO2002056905A2 (en)	2001-01-19	2002-01-21	Molecular antigen array
US39663702P	2002-07-19	2002-07-19

Publications (1)

Publication Number	Publication Date
PL369796A1 true PL369796A1 (pl)	2005-05-02

Family

ID=32996249

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL02369796A PL369796A1 (pl)	2001-10-05	2002-10-07	Koniugaty angiotensyna-nośnik i ich zastosowania

Country Status (11)

Country	Link
EP (1)	EP2090319A3 (pl)
JP (1)	JP2010189406A (pl)
KR (1)	KR101015508B1 (pl)
AT (1)	ATE421334T1 (pl)
BR (1)	BR0213117A (pl)
DE (1)	DE60230992D1 (pl)
DK (1)	DK1432443T3 (pl)
HK (1)	HK1067057A1 (pl)
IL (1)	IL160286A0 (pl)
MX (1)	MXPA04002644A (pl)
PL (1)	PL369796A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20140048119A (ko) *	2011-04-15	2014-04-23	고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸	Ｄｎａ 백신
AU2016207099C1 (en)	2015-01-15	2021-02-04	University Of Copenhagen	Virus-like particle with efficient epitope display
WO2017071713A1 (en)	2015-10-30	2017-05-04	University Of Copenhagen	Virus like particle with efficient epitope display
EP4132478A1 (en)	2020-04-09	2023-02-15	Finncure Oy	Mimetic nanoparticles for preventing the spreading and lowering the infection rate of novel coronaviruses
US12194157B2 (en)	2020-04-09	2025-01-14	Finncure Oy	Carrier for targeted delivery to a host

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4722840A (en)	1984-09-12	1988-02-02	Chiron Corporation	Hybrid particle immunogens
US4918166A (en)	1987-04-10	1990-04-17	Oxford Gene Systems Limited	Particulate hybrid HIV antigens
NZ235315A (en)	1989-09-19	1991-09-25	Wellcome Found	Chimaeric hepadnavirus core antigen proteins and their construction
WO1991010741A1 (en)	1990-01-12	1991-07-25	Cell Genesys, Inc.	Generation of xenogeneic antibodies
US5334394A (en)	1990-06-22	1994-08-02	The Regents Of The University Of California	Human immunodeficiency virus decoy
SE9003978D0 (sv)	1990-12-13	1990-12-13	Henrik Garoff	Dna expressionssystem baserade paa ett virus replikon
GB9101550D0 (en)	1991-01-24	1991-03-06	Mastico Robert A	Antigen-presenting chimaeric protein
GB9114003D0 (en)	1991-06-28	1991-08-14	Mastico Robert A	Chimaeric protein
GB9227068D0 (en)	1992-12-29	1993-02-24	British Bio Technology	Novel proteinaceous particles
AU6172194A (en)	1993-02-08	1994-08-29	Paravax, Inc.	Defective sindbis virus vectors that express (toxoplasma gondii) p30 antigens
US6015686A (en)	1993-09-15	2000-01-18	Chiron Viagene, Inc.	Eukaryotic layered vector initiation systems
WO1996030523A2 (en)	1995-03-31	1996-10-03	Hans Wolf	Antigen presentation system based on retrovirus-like particles
US5876727A (en)	1995-03-31	1999-03-02	Immulogic Pharmaceutical Corporation	Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
US5792462A (en)	1995-05-23	1998-08-11	University Of North Carolina At Chapel Hill	Alphavirus RNA replicon systems
ID18046A (id)	1996-08-20	1998-02-19	Takeda Chemical Industries Ltd	Senyawa siklik campuran, pembuatan dan penngunaannya.
US5770380A (en)	1996-09-13	1998-06-23	University Of Pittsburgh	Synthetic antibody mimics--multiple peptide loops attached to a molecular scaffold
AU748903B2 (en)	1997-06-24	2002-06-13	Proteus Molecular Design Limited	Angiotensin derivatives
TR200002338T2 (tr)	1998-02-12	2002-06-21	Immune Complex Corporation	Stratejik olarak yenilenmiş hepatit B çekirdek proteinler.
SE9801923D0 (sv)	1998-05-29	1998-05-29	Independent Pharmaceutical Ab	Nicotine vaccine
DE69929232T2 (de)	1998-10-21	2006-08-31	The United States Government As Represented By The Department Of Health And Human Services	Virusähnliche partikel zur induktion von autoantikörpern
DK1135162T3 (da)	1998-11-30	2009-01-19	Cytos Biotechnology Ag	Ordnet molekylær præsentation af allergener, fremstillingsfremgangsmåde samt anvendelse
BR0109919A (pt)	2000-04-07	2003-03-11	Univ Leeds Innovations Ltd	Proteìna, partìcula, molécula de ácido nucleico, célula hospedeira, processo para produzir uma proteìna, composição farmacêutica, uso de uma proteìna, e, método de vacinação profilática ou terapêutica de um indivìduo
WO2001085208A2 (en)	2000-05-05	2001-11-15	Cytos Biotechnology Ag	Molecular antigen arrays and vaccines
PT1294893E (pt)	2000-06-22	2006-08-31	Ucb Pharma Ltd	Modificacao do antigenio nuclear de hepatite b
US20030138769A1 (en)	2000-08-16	2003-07-24	Birkett Ashley J.	Immunogenic HBc chimer particles having enhanced stability
US7320793B2 (en)	2001-01-19	2008-01-22	Cytos Biotechnology Ag	Molecular antigen array

2002
- 2002-01-21 BR BR0213117-0A patent/BR0213117A/pt not_active IP Right Cessation
- 2002-01-21 MX MXPA04002644A patent/MXPA04002644A/es active IP Right Grant
- 2002-10-07 KR KR1020047002222A patent/KR101015508B1/ko not_active IP Right Cessation
- 2002-10-07 AT AT02800605T patent/ATE421334T1/de not_active IP Right Cessation
- 2002-10-07 DK DK02800605T patent/DK1432443T3/da active
- 2002-10-07 EP EP09150826A patent/EP2090319A3/en not_active Withdrawn
- 2002-10-07 IL IL16028602A patent/IL160286A0/xx not_active IP Right Cessation
- 2002-10-07 PL PL02369796A patent/PL369796A1/pl not_active Application Discontinuation
- 2002-10-07 DE DE60230992T patent/DE60230992D1/de not_active Expired - Lifetime
2004
- 2004-12-23 HK HK04110188.7A patent/HK1067057A1/xx not_active IP Right Cessation
2010
- 2010-04-01 JP JP2010085112A patent/JP2010189406A/ja active Pending

Also Published As

Publication number	Publication date
EP2090319A3 (en)	2009-10-28
HK1067057A1 (en)	2005-04-01
EP2090319A2 (en)	2009-08-19
DK1432443T3 (da)	2009-05-04
KR20050034573A (ko)	2005-04-14
MXPA04002644A (es)	2004-07-08
BR0213117A (pt)	2004-09-21
JP2010189406A (ja)	2010-09-02
DE60230992D1 (de)	2009-03-12
IL160286A0 (en)	2004-07-25
KR101015508B1 (ko)	2011-02-16
ATE421334T1 (de)	2009-02-15

Publication	Publication Date	Title
WO2003031466A3 (en)	2003-10-23	Angiotensin peptide-carrier conjugates and uses thereof
PL366826A1 (pl)	2005-02-07	Zmniejszanie immunogenności białek fuzyjnych
MXPA04006059A (es)	2004-09-27	Preparacion liofilizada que contiene anticuerpos contra el receptor del factor de crecimiento epidermico.
MY162525A (en)	2017-06-15	Process for concentration of antibodies and therapeutic products thereof
EP1553975B8 (en)	2023-04-12	Optimized fc variants and methods for their generation
AU4673099A (en)	2000-09-14	Use of bioadhesives and adjuvants for the mucosal delivery of antigens
MXPA03006093A (es)	2005-02-14	Derivados de n(fenilsulfonil)glicina y su uso terapeutico.
ATE252814T1 (de)	2003-11-15	Leuchstoff für lichtquellen und zugehörige lichtquelle
AP2003002752A0 (en)	2003-06-30	Immunogenic HBc Chimer particles having enhanced stability.
HK1086296A1 (en)	2006-09-15	Process for producing dipeptide
AP2003002751A0 (en)	2003-06-30	Malaria immunogen and vaccine
MXPA04004814A (es)	2004-08-11	Metodos para descubrir ligandos.
ATE261484T1 (de)	2004-03-15	Leuchtstoff für lichtquellen und zugehörige lichtquelle
MY127575A (en)	2006-12-29	Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
YU61103A (sh)	2006-05-25	Postupci za produkciju supstituisanih 2-(2-piridilmetil) sulfinil-1h-benzimidazola
IL150234A0 (en)	2002-12-01	Methods and compositions for the manufacture of ophthalmic lenses
IL160286A0 (en)	2004-07-25	Angiotensin peptide-carrier conjugates and uses thereof
ATE262600T1 (de)	2004-04-15	Herstellung von aluminium-silizium-legierungen
WO2002068475A3 (es)	2002-10-31	Composicion farmaceutica de fragmentos f(ab)2 de anticuerpos y un proceso para su preparacion
AU2003267551A1 (en)	2004-03-11	Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone
MXPA04004937A (es)	2004-08-11	Proceso para preparar 3,3??,3,6??,-tetraalquil-2,2??-bifenoles y 3,??,6,??-tetraalquil-5,??-dihalo-2,??-bifenoles.
SG185137A1 (en)	2012-11-29	Biologically active peptides
DE59610629D1 (de)	2003-09-04	Immunogenes konstrukt, verfahren zu dessen herstellung und verwendung als vakzine
AU2002354185A1 (en)	2003-06-30	Fused indole compound, process for producing the same, and use
WO2003015813A3 (en)	2004-06-17	Anti-tumor vaccines

Legal Events

Date	Code	Title	Description
2012-04-30	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)